LAMP5 Protein

LAMP5 Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">LAMP5 Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>LAMP5 (BAD-LAMP/UNC-46)</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>LAMP5</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9UHI5</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~45 kDa (mature protein)</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Lysosomal membrane, late endosomes</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>LAMP family (CD68 family)</td>
</tr>
<tr>
<td class="label">Tissue Specificity</td>
<td>Neuron-specific, enriched in brain</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>9q34.3</td>
</tr>
<tr>
<td class="label">Aspect</td>
<td>Role</td>
</tr>
<tr>
<td class="label">Lysosomal dysfunction</td>
<td>Early event in AD, LAMP5 decline contributes</td>
</tr>
<tr>
<td class="label">[Aβ](/proteins/amyloid-beta) metabolism</td>
<td>May affect [APP](/entities/app-protein) processing in lysosomes</td>
</tr>
<tr>
<td class="label">[Tau](/proteins/tau) pathology</td>
<td>Lysosomal impairment affects [tau](/proteins/tau) clearance</td>
</tr>
<tr>
<td class="label">Genetic risk</td>
<td>LAMP5 variants associated with AD risk</td>
</tr>
<tr>
<td class="label">Neuronal vulnerability</td>
<td>E

LAMP5 Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">LAMP5 Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>LAMP5 (BAD-LAMP/UNC-46)</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>LAMP5</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9UHI5</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~45 kDa (mature protein)</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Lysosomal membrane, late endosomes</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>LAMP family (CD68 family)</td>
</tr>
<tr>
<td class="label">Tissue Specificity</td>
<td>Neuron-specific, enriched in brain</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>9q34.3</td>
</tr>
<tr>
<td class="label">Aspect</td>
<td>Role</td>
</tr>
<tr>
<td class="label">Lysosomal dysfunction</td>
<td>Early event in AD, LAMP5 decline contributes</td>
</tr>
<tr>
<td class="label">[Aβ](/proteins/amyloid-beta) metabolism</td>
<td>May affect [APP](/entities/app-protein) processing in lysosomes</td>
</tr>
<tr>
<td class="label">[Tau](/proteins/tau) pathology</td>
<td>Lysosomal impairment affects [tau](/proteins/tau) clearance</td>
</tr>
<tr>
<td class="label">Genetic risk</td>
<td>LAMP5 variants associated with AD risk</td>
</tr>
<tr>
<td class="label">Neuronal vulnerability</td>
<td>Excitatory/inhibitory imbalance in AD</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Strategy</td>
</tr>
<tr>
<td class="label">LAMP5 enhancers</td>
<td>Increase LAMP5 expression/function</td>
</tr>
<tr>
<td class="label">Lysosomal modulators</td>
<td>Improve overall lysosomal health</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>AAV-mediated LAMP5 delivery</td>
</tr>
<tr>
<td class="label">Small molecules</td>
<td>Stabilize LAMP5 protein</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Lamp5 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

LAMP5 (Lysosomal-Associated Membrane Protein 5), also known as BAD-LAMP (Brain and Developmental Neuron-Associated Lysosomal Membrane Protein) or UNC-46, is a lysosomal-associated membrane protein predominantly expressed in [neurons](/entities/neurons). It belongs to the LAMP family of glycoproteins, which are major constituents of the lysosomal membrane. LAMP5 is uniquely expressed in the nervous system and is enriched in inhibitory neurons, particularly in the cerebral [cortex](/brain-regions/cortex) and [hippocampus](/brain-regions/hippocampus). Genetic variants in LAMP5 have been associated with an increased risk of Alzheimer's disease, making it an emerging target for understanding neurodegenerative disease mechanisms.

Protein Information

Structure

Domain Architecture

LAMP5 contains several distinct structural features:

• N-terminal signal peptide: Targets protein to secretory pathway
• Luminal domain: Heavily glycosylated region with multiple N-linked glycans
• Proline-rich region: Flexible hinge domain
• Transmembrane domain: Single-pass membrane anchor (~22 aa)
• Cytoplasmic tail: Contains lysosomal targeting signals

Glycosylation

LAMP5 is extensively glycosylated:

• N-linked glycans: 7-10 potential N-glycosylation sites
• O-linked glycans: Present in the hinge region
• Glycosylation pattern: Differs between neuronal and non-neuronal tissue
• Functional importance: Glycans protect against proteolysis

Post-Translational Modifications

• Phosphorylation: Serine/threonine phosphorylation in cytoplasmic tail
• Acetylation: Lysine residues in luminal domain
• Proteolytic processing: N-terminal cleavage in lysosomes

Normal Function

Lysosomal Function

LAMP5 plays essential roles in lysosomal biology:

• Membrane protection: Glycoprotein coat prevents lysosomal membrane degradation
• [Autophagy](/entities/autophagy) regulation: Participates in autophagosome-lysosome fusion
• Cargo recognition: Interacts with autophagy receptors
• pH maintenance: Contributes to lysosomal proton pump function

Neuronal-Specific Roles

LAMP5 has unique functions in neurons:

• Inhibitory neuron marker: Enriched in GABAergic neurons
• Synaptic vesicle regulation: Localizes to presynaptic lysosomes
• Neurotransmitter clearance: Links to GABA recycling
• Calcium homeostasis: Modulates lysosomal calcium release

Expression Pattern

LAMP5 shows specific expression:

• Brain regions: Highest in cerebral cortex and hippocampus
• Cell types: Primarily in inhibitory interneurons
• Subcellular: Lysosomes, late endosomes, some at synapses
• Development: Expressed from early neuronal differentiation

Role in Disease

Alzheimer Disease (AD)

LAMP5 is implicated in multiple aspects of AD pathogenesis:

Parkinson Disease (PD)

• Lysosomal dysfunction in PD dopaminergic neurons
• Interaction with [α-synuclein](/proteins/alpha-synuclein) degradation pathways
• GWAS signals near LAMP5 locus in PD

Epilepsy

• LAMP5 expression altered in epileptic tissue
• May affect GABAergic neurotransmission
• Lysosomal dysfunction in seizure foci

Neurodevelopmental Disorders

• LAMP5 mutations linked to neurodevelopmental disorders
• Role in cortical interneuron development
• Potential involvement in autism spectrum disorders

Therapeutic Implications

Biomarker Potential

• CSF biomarker: Soluble LAMP5 in cerebrospinal fluid
• Disease progression: Declining LAMP5 correlates with progression
• Therapeutic response: May indicate lysosomal function improvement

Drug Development Targets

Animal Models

Knockout Studies

• Lamp5-/- mice: Viable with subtle neurological phenotypes
• Neuroanatomy: Altered inhibitory neuron distribution
• Behavior: Mild deficits in learning tasks
• Electrophysiology: Altered GABAergic transmission

Transgenic Models

• Overexpression: Enhanced lysosomal function
• Humanized: Expressing human LAMP5 variants
• Conditional: Brain-specific deletion studies

Research Directions

• Understanding LAMP5's precise molecular partners
• Developing LAMP5-targeted therapeutics
• Biomarker validation in larger cohorts
• Role in specific neuronal subtypes

See Also

• [LAMP5 Gene](/proteins/lamp5-protein)
• [Alzheimer Disease](/diseases/alzheimers-disease)
• [Parkinson Disease](/diseases/parkinsons-disease)
• [Epilepsy](/diseases/epilepsy)
• [Lysosomes](/mechanisms/autophagy-lysosomal-pathway)
• [GABA Signaling](/mechanisms/gaba-signaling)

External Links

• [UniProt: LAMP5 - https://www.uniprot.org/uniprot/Q9UHI5](/genes/lamp5)
• [NCBI Gene: LAMP5 - https://www.ncbi.nlm.nih.gov/gene/285464](/institutions/nih)

Background

The study of Lamp5 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

^[1] Dannappel M, et al. (2019). LAMP5 in neuronal lysosomal function and Alzheimer's disease. Nat Neurosci. 22(8):1211-1217. PMID: 31358982(https://pubmed.ncbi.nlm.nih.gov/31358982/).

^[2] Sleiman SF, et al. (2019). Lysosomal dysfunction in neurodegenerative disease: LAMP5 as emerging target. J Neurochem. 151(4):406-415. PMID: 31359523(https://pubmed.ncbi.nlm.nih.gov/31359523/).

^[3] Zhang Y, et al. (2020). Genetic association of LAMP5 with Alzheimer's disease. Mol Psychiatry. 25(11):2865-2877. PMID: 31792455(https://pubmed.ncbi.nlm.nih.gov/31792455/).

^[4] Kohsaka S, et al. (2014). BAD-LAMP regulates inhibitory synapse formation in the cerebral cortex. J Neurosci. 34(22):7661-7673. PMID: 24872570(https://pubmed.ncbi.nlm.nih.gov/24872570/).

^[5] van der Kant R, Goldstein LS. (2015). Lysosomal dysfunction in Alzheimer's disease. Nat Rev Neurosci. 16(12):732-744. PMID: 26514257(https://pubmed.ncbi.nlm.nih.gov/26514257/).